In another alternate version, which I prefer to call reality, it might be due to the fact NYMX is a pretentious two bit company which has never produced anything of value and its star product finished phase three trials four months ago and the results have still not been released.
Investing in NYMX for me is a bit like reading Alice in Wonderland.
Interesting huge volume in 5 Sept puts but the price of the put actually went down. Don't know what to make of it. Double the days volume in the first hour. Looks like results will be out soon.
Good luck in China but please don't come back !
Yes this is the state of our country when greedy, brainless pigs like you can commit fraud and boast about it on internet message boards.
THC paid a lot of fines for fraud to the Government; no wonder it made money.
Based on your postings on this board you are arrogant; abusive and have shallow knowledge and make rash decisions or maybe its just the presenile dementia causing a change in your personality.
It has nothing to do with what the cardiologist thinks. They are getting paid either way and you claim to have been a CEO of a Hospital! What will matter are the results.
Learn English; I talked about you being a secretary to a CEO. Looks like you are losing your eyesight along with your brain.
Ex calm down. Just because you were the secretary to a CEO of a hospital in small town MO does not mean anything. If you actually had been a CEO you would have been fired just like your wife fired you. See its easy to be tough on an anonymous message board. I learn from you!
The average life expectancy of a Stage four CHF is six months- You know that because you talk to Rosa daily right? Living two years after stage four CHF is good not bad but not as good as living more than two years.
I have not posted here for a long time because of two people with presenile dementia hogging the board but some of his questions are worth looking into if you are long SSH. What is the survival of SSH implanted patients? Max. of 2years per Bigs and I can not find anything that contradicts his statement. Anyone else have any different information? Maybe Ex can call Rosa and find out.
I remember Allergan when it was purely an eye products company at that time botox was only used for temporay paralysis of eye muscles for squint and then they discovered other uses for botox which were unique and look where they are now.
This handicapping of projected sales figues is an useless exercise in my view at this point in time and akin to day dreaming because execution depends on so many other factors as well but if you are going to daydream you might as well compare it to a similar succesful product.
Flomax costs around $ 3000 a year,most likely nymox will be priced in this price range and will surely be approved by insurances as its also more cost effective for them. Another way to value this is look at companies with a similar single succesfull product and see their marketcap; Allergan would be a good example.
I was looking at this.
MONTREAL, Aug. 6, 2014 (GLOBE NEWSWIRE) -- This press release is being disseminated as required by the early warning requirements of applicable securities laws. Paul Averback MD announces today that he has sold in a private transaction for financial planning purposes 470,600 common shares of Nymox Pharmaceutical Corporation ("Nymox") for a total consideration of US $2,400,000 ($2,622,240 CDN). This sale represents 1.3% of the shares of Nymox issued and outstanding. As a result of this sale, Dr. Averback continues to own and control 10,931,448 shares of Nymox or approximately 31% of the shares of Nymox issued and outstanding.
This announces he has sold but gives no information as to when he sold. Since this is dated August 6, 2014; I assume the transaction happened earlier but I see you are thinking the date of the announcement is the same as the date they were sold. Hmm.....This would imply that the results are not going to be released soon.
The phraseology of the letter suggests they were referring to an event in the past. I was wondering what was the time limit on this reporting ie how long do they have (after they sell) before they have to report.
Nothing wrong with my mood :) Thank you for asking.
I bought the majority of shares sold today, A selling his shares is just noise. I would like to know when he sold his shares though; anyone have a clue?
I never said its a proper or legit group. Look at their investments. I agree research on them is hard to do; I got access to more information by the way back machine two or three years back.
Shorting a five dollar stock is peanuts for them; they have poured millions into the co. over years.
Not necessary if LG is a collection of individual and each owns less than 5% ( they can even split it among family members). From my research it appears LG is a group of wealthy individuals who collectively invest in projects. Look at the volume of this stock, there is no volume to support your hypothesis that they sell after 60-90 days and who is then buying the stock? If LG I selling no amount of retail interest would keep the stock price stable.
You are wrong about it being 96% retail. Yahoo and other sites are not accurate for this. I would guess Doc owns about 40-50% of the company and other insiders principally a shady hedge fund/banker from Panama/Switzerland own around 30%. If you dig into LG funds history they have a history of backing such enterprises; their other major investment that I know of is a mine in S. America.
This is why Dr. A cares a fig about shareholders; his principal means of finance is LG.
This is the end of the third month, not second month.
Secondly Dr. A was unequivocal in his assertion that results of first phase three would be released in 2013.
FROM THE NYMOX WEBSITE
Nymox Announces Completion of Patient Enrollment in Pivotal U.S. Phase 3 BPH Study
Topic: R&D: BPH (enlarged prostate) Treatments
November 28, 2012: Nymox announced today completion of patient enrollment in the Company’s pivotal U.S. Phase 3 NX02-0017 Study of NX-1207 for BPH. This study is now closed to further enrollment. Top-line results from the large Phase 3 Study are expected in late 2013.
That statement was true ten years ago. Flomax the currently used drug is reported to show a mean improvement of 9.7 at the 0.8 mg dose and 9.4 at the 0.4 mg dose.